ECM1 and breast cancer: We showed that the level of ECM1 mRNA is strongly and positively correlated with that of phosphorylated Src at Y416 residue, a surrogate marker for its activation, in ER+ breast cancer cells, suggesting that ECM1 may promote endocrine resistance by the activation of Src.